Our Company
Who Are We?
We are BIOTECH THERAPEUTICS, LLC
-
Biotech startup founded 2022*, based in New Haven, CT & Estero, FL
-
Specialize in Cell Therapy, AKA MSCs and Exosome nanoparticles
-
Yale Medical School classmate Co-Founders:
-
CEO John Barchilon, MD
-
CSO Professor Phil Askenase, MD
-
While the startup was founded in 2022, Professor Askenase has been working on exosomes for a dozen years at the Yale School of Medicine, and Dr. Barchilon for 4 years independently.
*
We have a prospective treatment for the rescue of cognition in
Alzheimer’s disease and the dementia of Long Covid
based on successful murine studies
Our Team
John Barchilon, MD
CEO, Founding Partner
A graduate of Dartmouth, John earned his M.D. at Yale, where (as a student) he designed, raised funding, built and developed fiberoptic endoscopic and cardiac catheters, for which he was granted a U.S. patent, subsequently licensed to Cooper Laboratories and still in use. He trained briefly in surgery at The New York Hospital-Cornell Medical Center, then served as captain and C.O. of the 309th Surgical Detachment, II Corps, USAR, then returned to Yale as a fellow and faculty instructor where he did research with Richard Gershon in immunology studying B-cells and T-cells, resulting in a discovery that helped explain the mechanism by which the HIV caused AIDS; after which he took additional training in internal medicine, and ultimately became the Corporate Medical Director for Johnson & Higgins on Wall Street. John has recruited stars: Nobel-laureate chemist Melvin Calvin, Cal Tech’s botanical tissue cloning expert James Bonner, Congressional consultant on gene-splicing Nina Fedoroff, and fuel crop expert Tim Peoples for a biomass energy project & IPO in the 1980’s of which he was CEO. He was elected to the New York Academy of Sciences. In a white paper for Presidential candidate George H. W. Bush he advised on biomass/biotechnology matters, and New York City Mayoral Candidate Joel Harnett on healthcare and patient care issues. His letter in The London Financial Times calling for US tariffs in 2012 was positively received by two presidential candidates in 2015. John has been CEO of two medical practices in Los Angeles, and a Sr. Attending Urgent Care Physician at Kaiser Permanente in Woodland Hills, Southern California. He has pursued research on Covid-19 since November of 2019.
A widower since 2015, John is the busy father of 28- year-old twins.
Phil Askenase, MD
CSO, Founding Partner
Professor of Medicine & Pathology, Rheumatology and Clinical Immunology Section, Department of Medicine, Yale School of Medicine; 333 Cedar St, New Haven, Conn. 06510;
Dr Askenase was brought up in Long Island, NY where he played three
sports in high school. Then on to Brown Univ in Providence, RI where he
was on the starting freshman basketball team and excelled in academics;
graduating Junior Phi Beta, Kappa and Magna Cum Laude. Then to Yale
Medical School where he wrote a thesis resulting from his experiments on
viral infection induced auto immunity. Then on to Internship and Residency
in Medicine at the Harvard Medical School Unit of the Boston City Hospital.
For subsequent military service Dr. Askenase joined the Navy and was
assigned to the NIH in Bethesda, Maryland. There he developed the solid
phase immune assay and published studies on experiments demonstrating
circulating Complement fixing immune complexes in immune glomerulo-
nephritis with Dr. Edward J, Leonard, and studied clinical autoimmune
diseases with Dr. John Decker. Thereafter, Dr Askenase won a fellowship
from The British/American Heart Foundation, going to study under Dr.
Geoffrey Asherson at the London Hospital, who was the secretary of the
British Society of Immunologists and performing early studies in mice of
standard systems previously developed in guinea pigs and rabbits. There
Dr Askenase was able to interact with many leaders in world immunology
and get new ideas about a new form of cellular immunity known as cutaneous
basophil hypersensitivity, in which there was remarkable large participation
of basophils when examined by electron microscopy techniques. On return to
Yale, now on the Medical School faculty, he worked out the first procedures for
demonstrating the basophils by ordinary techniques that allowed viewing and
quantitation more easily. This led to discovery of a previously unknown
participation of antibodies and participation in crucial responses to parasites.
Returning to mice he discovered the critical role of masts cells in cellular immunity
leading to a variety of discoveries. Along the way, working in immune tolerance
there was discovery of an enigmatic factor. With the help of Sidney Altman at
Yale and colleagues at the Rockefeller their work led to discovery of participating
exosomes delivering miRNA guided by Ig antibody light chains. This led to
use of exosomes in healing responses of mesenchymal stromal cells in a variety
of responses, culminating in strong healing of spinal cord injury, their use by the
nasal route and potential for new effective and safe treatments for Long Covid
and Alzheimer's disease.
Dan Goldberg, MS
COO
MS Engineering, RIA, owner of Simi Valley Investment Services
Simi Valley, CA
www.simi-investments.com<http://www.simi-investments.com/>
Jim Froelich, CPA
CFO
CEO Schwartz & Froelich, Inc
Santa Monica, CA
Ryan Harding, LLD
Legal Counsel
Akerman & Associates
Expert Intellectual Property Attorneys
Mark Passler
Legal Counsel
Akerman & Associates
Expert Intellectual Property Attorneys
Weston Goldberg, MS
Assoc CTO
Software Engineering, 2023
Thousand Oaks, CA
Weston Goldberg is a Computer Science graduate of California State University, Channel Islands, with hands-on experience in IT and electronics. Based in southern California, Weston has a strong background in troubleshooting and maintaining diverse technology systems, from Windows/Linux computers to network equipment and digital projectors. With a passion for custom computer builds since the age of 15, Weston has leveraged this expertise to create tailored solutions, including two systems for CEO John Barchilon. His technical proficiency spans many programming languages, complemented by skills in system configuration and database management.
Lynette Johnson
Accounting/Bookkeeping
Konabay Accounting